HomePage | Biosensors International Ltd

WELCOME TO BIOSENSORS

our news

Updated DAPT ESC guidelines

February 06,2018 | News | BioFreedom
BioFreedom now listed as stent of choice in ESC DAPT guidelines, for 1 month-ultra short DAPT in patients with stable CAD in whom longer DAPT regimes poses safety concerns.
(European Heart Journal (2018)39, 213-254)
READ MORE

HIGH BLEEDING RISK PATIENTS

January 20,2010 | News | BioFreedom
BioFreedom is the only active stent with CE mark for ultra-short 1 month DAPT, in High bleeding Risk (HBR) patients, supported by clinical data from a double-blind randomized controlled trial.
READ MORE

ELDERLY PATIENTS WITH HIGH BLEEDING RISK

February 26,2018 | News | BioFreedom
In the pre-specified elderly subgroup of LEADERS FREE, when considering age over 75 as sole criteria, BioFreedom demonstrated a 0.7% definite or probable stent thrombosis rate at one year.
READ MORE

INNOVATIVE TECHNOLOGIES